UnitedHealth Group Inc. reported first‑quarter 2026 results that surpassed expectations, with revenue of $111.72 billion—up 2 % from $109.6 billion a year earlier—and adjusted earnings per share of $7.23, beating the consensus estimate of $6.59 by $0.64 per share.
Operating margin expanded to 6.6 % from 6.2 % a year ago, driven by stronger pricing in UnitedHealthcare and Optum and disciplined cost control. The medical care ratio fell to 83.9 % from 84.8 %, a key indicator of improved medical cost management that has been a focus for the company’s turnaround strategy.
Segment performance showed UnitedHealthcare generating $86.3 billion in revenue, while Optum Insight contributed $5.1 billion. Optum Health, however, experienced a year‑over‑year decline in revenue, reflecting mixed performance within the broader Optum portfolio.
On the earnings call, UnitedHealth raised its full‑year adjusted EPS guidance to more than $18.25 per share, up from the prior outlook of more than $17.75, and reaffirmed its revenue guidance of greater than $439 billion, signaling confidence in continued top‑line growth and margin recovery.
Management highlighted the drivers behind the results. CEO Andrew Witty said, "Our strong first‑quarter results reflect our commitment to operational excellence and strategic focus on margin recovery. We are confident in our ability to deliver sustainable growth and shareholder value." CFO Wayne DeVeydt added, "pricing discipline, cost management, and favorable reserve development" were key to the medical care ratio improvement. CEO Stephen Hemsley noted, "We are continuing to help simplify and modernize health care for the people and care providers we serve, bringing greater value, affordability, transparency and connectivity," and added, "This management team believes we are a long way from performing to our full potential, and we're committed to getting to that potential quarter after quarter."
Investors reacted positively to the results, with a focus on the improved medical care ratio and the earnings beat, underscoring confidence in UnitedHealth’s cost‑control trajectory and its outlook for continued margin expansion.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.